Why the study?
Is MLPA combined with NGS effective for detecting dystrophin gene mutations in children with suspected DMD/BMD?
Observational (n=92)
Is MLPA combined with NGS effective for detecting dystrophin gene mutations in children with suspected DMD/BMD?
Answers are grounded in this paper and cite their sources.
The combination of MLPA and NGS is an effective diagnostic strategy for identifying dystrophin gene mutations in children with suspected DMD/BMD.
INTRODUCTION: Duchenne and Becker muscular dystrophies (DMD and BMD) are X-linked myopathies caused by mutations of the dystrophin gene. METHODS: Multiplex ligation-dependent probe amplification (MLPA) combined with next-generation sequencing (NGS) of the exons of the dystrophin gene were performed in 92 suspected DMD/BMD patients. Patients with negative results were subjected to additional muscle diseases panel tests. RESULTS: DNA rearrangements were detected in 65 (70.65%) patients using MLPA. The deletions primarily clustered at exons 45-55, followed by exons 2-19. The duplication locations were in contrast to previous studies, which involved the 3' end of the gene. A total of 21 cases with point mutations were detected by NGS analysis. Furthermore, 6 previously unreported mutations were detected. Limb-girdle muscular dystrophy was confirmed in 2 patients after analysis with the muscle diseases panel. CONCLUSIONS: MLPA combined with NGS was effective for detection of the mutations in dystrophin gene exons. Muscle Nerve 56: 117-121, 2017.
No takes yet. Share an insight, caveat, or question.
Zhong et al. (2016) conducted an observational in Duchenne and Becker muscular dystrophies (n=92). Multiplex ligation-dependent probe amplification (MLPA) combined with next-generation sequencing (NGS) was evaluated on Detection of DNA rearrangements and point mutations in the dystrophin gene.
Synapse has enriched 10 related papers. Consider them for comparative context: